Nat Habit Raises Rs 142 Crore in Round Led by Trident Growth Partners

Ayurvedic personal care brand Nat Habit has raised Rs 142 crore in a funding round led by Trident Growth Partners, confirming an earlier scoop about the transaction.

The Rs 142 crore figure anchors one of the larger recent financing rounds in India's Ayurveda-focused consumer segment. Trident Growth Partners, the lead investor in the deal, now backs a brand that has built its position in the natural and Ayurvedic personal care market.

What does the confirmed deal tell us?

The confirmation closes the loop on a story that had circulated as an unconfirmed report before the official details emerged. Nat Habit's Rs 142 crore raise, with Trident Growth Partners at the head of the table, gives the company fresh capital to scale a business operating in one of India's most competitive consumer categories.

Ayurvedic and natural personal care has attracted sustained investor interest in India, as consumers shift toward products marketed on traditional formulations and ingredient transparency. Nat Habit sits squarely in that segment.

For Trident Growth Partners, the deal marks a concrete bet on the category. Leading a Rs 142 crore round signals conviction in the brand's positioning and its ability to grow within a market crowded with both legacy players and venture-backed challengers.

Why does the round matter for the Ayurvedic segment?

The size of the raise stands out. At Rs 142 crore, the round represents meaningful capital for a brand operating in a category where distribution, product development and brand building all demand sustained investment.

The deal structure — Trident Growth Partners leading, with the round totaling Rs 142 crore — positions Nat Habit to press its advantage while consumer demand for Ayurvedic formulations continues to shape purchasing decisions across India's personal care market.

Confirmation of the round also settles speculation about the company's fundraising plans. Reports of the transaction had surfaced before the details were verified; the confirmed figure and lead investor now put hard numbers on the story.

What comes next?

The capital injection gives Nat Habit room to pursue its next phase of growth. How the company deploys the Rs 142 crore — across product lines, distribution or marketing — will determine whether it can convert investor backing into durable market share in the Ayurvedic personal care space, where competition for the natural-care consumer remains intense.